What Is Ozempic (Semaglutide)?
The first GLP-1 receptor agonist to receive a license to treat type 2 diabetes became semaglutide under the brand name Ozempic. It also acts the same way as the natural hormone of the body, GLP-1, since insulin prevents the glucagon, slows the emptying of the stomach, and lessens the appetite. The treatments do not aid individuals in...
...
You've reached your August article limit
Free readers can access 1 article per month. Subscribe to Silver for more.
Already a subscriber? Log in

